BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pokorná J, Pachl P, Karlukova E, Hejdánek J, Řezáčová P, Machara A, Hudlický J, Konvalinka J, Kožíšek M. Kinetic, Thermodynamic, and Structural Analysis of Drug Resistance Mutations in Neuraminidase from the 2009 Pandemic Influenza Virus. Viruses 2018;10:E339. [PMID: 29933553 DOI: 10.3390/v10070339] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Kim H, Kang H, Kim HN, Kim H, Moon J, Guk K, Park H, Yong D, Bae PK, Park HG, Lim EK, Kang T, Jung J. Development of 6E3 antibody-mediated SERS immunoassay for drug-resistant influenza virus. Biosens Bioelectron 2021;187:113324. [PMID: 34020222 DOI: 10.1016/j.bios.2021.113324] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Kumar S, Goicoechea S, Kumar S, Pearce CM, Durvasula R, Kempaiah P, Rathi B, Poonam. Oseltamivir analogs with potent anti-influenza virus activity. Drug Discovery Today 2020;25:1389-402. [DOI: 10.1016/j.drudis.2020.06.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Zima V, Albiñana CB, Rojíková K, Pokorná J, Pachl P, Řezáčová P, Hudlicky J, Navrátil V, Majer P, Konvalinka J, Kožíšek M, Machara A. Investigation of flexibility of neuraminidase 150-loop using tamiflu derivatives in influenza A viruses H1N1 and H5N1. Bioorganic & Medicinal Chemistry 2019;27:2935-47. [DOI: 10.1016/j.bmc.2019.05.024] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
4 Williams CJ, Richardson DC, Richardson JS. The importance of residue-level filtering and the Top2018 best-parts dataset of high-quality protein residues. Protein Sci 2021. [PMID: 34779043 DOI: 10.1002/pro.4239] [Reference Citation Analysis]
5 Zhao H, Jiang S, Ye Z, Zhu H, Hu B, Meng P, Hu Y, Zhang H, Wang K, Wang J, Tian Y. Discovery of hydrazide-containing oseltamivir analogues as potent inhibitors of influenza A neuraminidase. Eur J Med Chem 2021;221:113567. [PMID: 34082224 DOI: 10.1016/j.ejmech.2021.113567] [Reference Citation Analysis]
6 Tunstall T, Portelli S, Phelan J, Clark TG, Ascher DB, Furnham N. Combining structure and genomics to understand antimicrobial resistance. Comput Struct Biotechnol J 2020;18:3377-94. [PMID: 33294134 DOI: 10.1016/j.csbj.2020.10.017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
7 Östbye H, Gao J, Martinez MR, Wang H, de Gier JW, Daniels R. N-Linked Glycan Sites on the Influenza A Virus Neuraminidase Head Domain Are Required for Efficient Viral Incorporation and Replication. J Virol 2020;94:e00874-20. [PMID: 32699088 DOI: 10.1128/JVI.00874-20] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
8 Rabalski L, Szewczyk B, Zagminas K, Griskevicius A, Lepek K. Coding-Complete Genome Sequences of Six Influenza Type A Strains Circulating in Lithuania in the 2009-2010 Epidemic Season. Microbiol Resour Announc 2021;10:e01274-20. [PMID: 33414352 DOI: 10.1128/MRA.01274-20] [Reference Citation Analysis]
9 Gregor J, Radilová K, Brynda J, Fanfrlík J, Konvalinka J, Kožíšek M. Structural and Thermodynamic Analysis of the Resistance Development to Pimodivir (VX-787), the Clinical Inhibitor of Cap Binding to PB2 Subunit of Influenza A Polymerase. Molecules 2021;26:1007. [PMID: 33673017 DOI: 10.3390/molecules26041007] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Medaglia C, Zwygart AC, Silva PJ, Constant S, Huang S, Stellacci F, Tapparel C. Interferon Lambda Delays the Emergence of Influenza Virus Resistance to Oseltamivir. Microorganisms 2021;9:1196. [PMID: 34205874 DOI: 10.3390/microorganisms9061196] [Reference Citation Analysis]